Clinical progress of cemented prosthesis as spacer inserted in two-stage revision for periprosthetic joint infection following total hip arthroplasty

doi:10.3877/cma.j.issn.1674-134X.2021.01.013

Abstract

Abstract:

Periprosthetic joint infection(PJI)is a disastrous complication after total hip arthroplasty(THA), while two-stage revision remains the most effective solution among all the therapeutic treatments of PJI. The insertion of traditional articulating antibiotic-loaded cement spacer reaches high eradication rate and provides improved range of movement of hip. However, patients still report poor hip function、health quality and satisfaction during the interim phase. The cemented prosthesis spacer coated with antibiotic-loaded cement such as PROSTALAC system is an evolutionary technique, which has been reported satisfied clinical outcome in recent researches but not widely used worldwide. This review aimed to summarize the data of design、eradication rate、function and health quality during interim phase of the cemented prosthesis spacer from previous literature, explore the possibility of the long-term spacer insertion without second surgery, and provide reference for the prospective studies of the cemented prosthesis in the future.

Key words: Joint prosthesis, Infection, Reoperation, Bone cements, Therapeutics

Jingchun Ma, Qiaojie Wang, Hao Shen, Xianlong Zhang. Clinical progress of cemented prosthesis as spacer inserted in two-stage revision for periprosthetic joint infection following total hip arthroplasty[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2021, 15(01): 78-82.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-134X.2021.01.013

https://zhgjwkzz.cma-cmc.com.cn/EN/Y2021/V15/I01/78

References 24

[1]	Parvizi J, Fassihi SC, Enayatollahi MA. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty[J]. Orthop Clin North Am, 2016, 47(3): 505-515.
[2]	Salvati EA, Gonzalez Della Valle A, Masri BA, et al. The infected total hip arthroplasty[J]. Instr Course Lect, 2003, 52: 223-245.
[3]	Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States[J/OL]. J Arthroplasty, 2012, 27(8 Suppl): 61-5.e1. doi: 10.1016/j.arth.2012.02.022.
[4]	Berend KR, Lombardi AV, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality[J]. Clin Orthop Relat Res, 2013, 471(2): 510-518.
[5]	Hofmann AA. Two-stage exchange is better than direct exchange in the infected THA[J]. Orthopedics, 1999, 22(10): 918.
[6]	Engesæter LB, Dale H, Schrama JC, et al. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register[J]. Acta Orthop, 2011, 82(5): 530-537.
[7]	Corona PS, Vicente M, Carrera L, et al. Current actual success rate of the two-stage exchange arthroplasty strategy in chronic hip and knee periprosthetic joint infection[J]. Bone Joint J, 2020, 102-B(12): 1682-1688.
[8]	Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America[J/OL]. Clin Infect Dis, 2013, 56(1): e1-e25. doi: 10.1093/cid/cis966.
[9]	Kuzyk PR, Dhotar HS, Sternheim A, et al. Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes[J]. J Am Acad Orthop Surg, 2014, 22(3): 153-164.
[10]	Jones CW, Selemon N, Nocon A, et al. The influence of spacer design on the rate of complications in two-stage revision hip arthroplasty[J]. J Arthroplasty, 2019, 34(6): 1201-1206.
[11]	Barreira P, Leite P, Neves P, et al. Preventing mechanical complications of hip spacer implantation: technical tips and pearls[J]. Acta Orthop Belg, 2015, 81(2): 344-348.
[12]	Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: current status[J]. Acta Orthop, 2006, 77(4): 628-637.
[13]	Biring GS, Kostamo T, Garbuz DS, et al. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study[J]. J Bone Joint Surg Br, 2009, 91(11): 1431-1437.
[14]	Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip[J]. Orthop Clin North Am, 1993, 24(4): 751-759.
[15]	Chalmers BP, Mabry TM, Abdel MP, et al. Two-stage revision total hip arthroplasty with a specific articulating antibiotic spacer design: reliable periprosthetic joint infection eradication and functional improvement[J]. J Arthroplasty, 2018, 33(12): 3746-3753.
[16]	Tsung JD, Rohrsheim JA, Whitehouse SL, et al. Management of periprosthetic joint infection after total hip arthroplasty using a custom made articulating spacer (CUMARS); the Exeter experience[J]. J Arthroplasty, 2014, 29(9): 1813-1818.
[17]	Zhang W, Fang X, Shi T, et al. Cemented prosthesis as spacer for two-stage revision of infected hip prostheses: a similar infection remission rate and a lower complication rate[J]. Bone Joint Res, 2020, 9(8): 484-492.
[18]	Masri B, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system[J]. J Arthroplasty, 1998, 13(3): 331-338.
[19]	Neut D, Van DH, Stokroos I, et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery[J]. J Antimicrob Chemother, 2001, 47(6): 885-891.
[20]	Cabo J, Euba G, Saborido A, et al. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections[J]. J Infect, 2011, 63(1): 23-31.
[21]	Fink B, Vogt S, Reinsch M, et al. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses[J]. Clin Orthop Relat Res, 2011, 469(11): 3141-3147.
[22]	Veltman ES, Moojen DJ, Glehr M, et al. Similar rate of infection eradication for functional articulating, prefabricated and custom-made spacers in 2-stage revision of the infected total hip: a literature review[J]. Hip Int, 2016, 26(4): 319-326.
[23]	Scharfenberger A, Clark M, Lavoie G, et al. Treatment of an infected total hip replacement with the PROSTALAC system. Part 2: Health-related quality of Life and function with the PROSTALAC implant in situ[J]. Can J Surg, 2007, 50(1): 29-33.
[24]	Beaupre LA, Stampe K, Masson E, et al. Health-related quality of Life with long-term retention of the PROSthesis of antibiotic loaded acrylic cement system following infection resolution in low demand patients[J/OL]. J Orthop Surg (Hong Kong), 2017, 25(2): 2309499017716257. doi: 10.1177/2309499017716257.

Please choose a citation manager

Content to export